Scarica l'app Stockscreener
5.08
4.87%
-0.26
Dopo l'orario di chiusura:
4.99
-0.09
-1.77%
Taysha Gene Therapies Inc Azioni (TSHA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
13.73%
1.986
|
2.302 | 2.022 | 1.788 | 1.112 |
Operating Expenses
|
21.14%
28.74
|
23.72 | 21.95 | 27.69 | 22.41 |
| Benefits Costs and Expenses |
21.14%
28.87
|
23.83 | 20.81 | - | - |
| Costs And Expenses |
21.14%
28.87
|
23.83 | 20.81 | 27.69 | 22.41 |
| Operating Income/Loss |
24.89%
-26.75
|
-21.42 | -19.93 | -25.90 | -21.30 |
| Nonoperating Income/Loss |
19.44%
-0.129
|
-0.108 | 1.147 | 0.374 | 0.371 |
| Income/Loss From Continuing Operations Before Tax |
24.86%
-26.88
|
-21.53 | -18.79 | 1.788 | 1.112 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
24.86%
-26.88
|
-21.53 | -18.79 | -25.52 | -20.93 |
|
Net Income/Loss
|
24.86%
-26.88
|
-21.53 | -18.79 | -25.52 | -20.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.65%
297.99
|
269.31 | 6.0824 | 267.82 | 232.82 |
| Diluted Average Shares |
10.65%
297.99
|
269.31 | 6.0824 | 267.82 | 232.82 |
| Basic Earnings Per Share |
12.50%
-0.09
|
-0.08 | -0.07 | -0.10 | -0.09 |
| Diluted Earnings Per Share |
12.50%
-0.09
|
-0.08 | -0.07 | -0.10 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):